drugset / Trial / NCT00184587

Prophylactic Treatment of Episodic Cluster Headache

NCT00184587 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether candesartan cilexetil are effective prophylactic treatment of episodic Cluster headache

Timeline

Start
2005-03
Primary completion
2009-06
Completion
2009-12

Outcome

Missed primary endpoint

paper The difference between the candesartan and placebo group was not significant with the pre-planned non-parametric ranking test PMID 23598371 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan cilexetil Unknown 32 mg —